The insider sales are too small to signal a change in fundamentals. Monitor next 10-Q for any guidance revision or royalty revenue trends.
LGND drugs
LGND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $299.00entry
- T+1 · 11d ago +2.41%α +2.10% · $306.20
- T+5 · 5d ago +5.78%α +2.49% · $316.27
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Two insiders at Ligand Pharmaceuticals sold a total of $311K in open-market sales within a week of the company's Q3 2026 earnings release. The CLO sold under a 10b5-1 plan, while a director sold without one. The total value is 0.005% of the $6.1B market cap, making the cluster trivial in scale.
Key Financial Metrics
Key Facts
- Total open-market sales: $311K (0.005% of $6.1B market cap)
- CLO Andrew Reardon sold $87K under a 10b5-1 plan
- Director Jason Aryeh sold $224K without a 10b5-1 plan
- Sales occurred within 6 days of Q3 2026 earnings (royalty revenue +51% YoY, raised EPS guidance)
- No C-suite CEO or CFO trades in the cluster
Financial Impact
Total insider sales of $311K, negligible relative to $6.1B market cap
Risk Factors
- Insider sales are trivial in size and do not indicate material bearish conviction
- CLO's sale under a 10b5-1 plan suggests pre-planned liquidity, not a reaction to earnings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LGND-1793827435938 |
Track record
29 reports on LGND
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 1/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Viewing Entry $299.00 Now $301.71 +0.91% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers